Global Breast Cancer Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	168 Pages	TechNavio	January, 2024	INF18475412

Best Price Guarantee
Price	from $2,500
Length	168 Pages
Publisher	TechNavio
Published Date	January, 2024
SKU	INF18475412

Global Breast Cancer Therapeutics Market 2024-2028

The breast cancer therapeutics market is forecasted to grow by USD 15.64 bn during 2023-2028, accelerating at a CAGR of 8.4% during the forecast period. The report on the breast cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of breast cancer, robust pipeline and new drug approvals, and rising number of patient support initiatives.

Technavio's breast cancer therapeutics market is segmented as below:

By Disease Type
Invasive breast cancers
Ductal carcinoma in situ
By Therapy
Targeted therapy
Hormonal therapy
Chemotherapy
By Geography
North America
Europe
Asia
Rest of World (ROW)

This study identifies the emerging novel therapeutics as one of the prime reasons driving the breast cancer therapeutics market growth during the next few years. Also, the availability of improved diagnostic modalities and rise in strategic collaborations will lead to sizable demand in the market.

The report on the breast cancer therapeutics market covers the following areas:

Breast cancer therapeutics market sizing
Breast cancer therapeutics market forecast
Breast cancer therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast cancer therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Clovis Oncology Inc., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Novartis AG, PerkinElmer Inc, Pfizer Inc., Puma Biotechnology Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the breast cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Chart on Market Overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Chart on Global Market Characteristics
  - Table Executive Summary - Chart on Market by Geography
  - Table Executive Summary - Chart on Market Segmentation by Disease Type
  - Table Executive Summary - Chart on Market Segmentation by Therapy
  - Table Executive Summary - Chart on Incremental Growth
  - Table Executive Summary - Data Table on Incremental Growth
  - Table Executive Summary - Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2023
- Market outlook: Forecast for 2023-2028
  - Table Chart on Global - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
  - Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Historic Market Size
- Global breast cancer therapeutics market 2018 - 2022
  - Table Historic Market Size - Data Table on global breast cancer therapeutics market 2018 - 2022 ($ billion)
- Disease Type Segment Analysis 2018 - 2022
  - Table Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
- Therapy Segment Analysis 2018 - 2022
  - Table Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)
- Geography Segment Analysis 2018 - 2022
  - Table Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- Country Segment Analysis 2018 - 2022
  - Table Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2023 and 2028
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Bargaining power of suppliers
  - Table Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Threat of new entrants
  - Table Threat of new entrants - Impact of key factors in 2023 and 2028
- Threat of substitutes
  - Table Threat of substitutes - Impact of key factors in 2023 and 2028
- Threat of rivalry
  - Table Threat of rivalry - Impact of key factors in 2023 and 2028
- Market condition
  - Table Chart on Market condition - Five forces 2023 and 2028
Market Segmentation by Disease Type
- Market segments
  - Table Chart on Disease Type - Market share 2023-2028 (%)
  - Table Data Table on Disease Type - Market share 2023-2028 (%)
- Comparison by Disease Type
  - Table Chart on Comparison by Disease Type
  - Table Data Table on Comparison by Disease Type
- Invasive breast cancers - Market size and forecast 2023- 2028
  - Table Chart on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Invasive breast cancers - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Invasive breast cancers - Year-over-year growth 2023-2028 (%)
- Ductal carcinoma in situ - Market size and forecast 2023- 2028
  - Table Chart on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)
- Market opportunity by Disease Type
  - Table Market opportunity by Disease Type ($ billion)
  - Table Data Table on Market opportunity by Disease Type ($ billion)
Market Segmentation by Therapy
- Market segments
  - Table Chart on Therapy - Market share 2023-2028 (%)
  - Table Data Table on Therapy - Market share 2023-2028 (%)
- Comparison by Therapy
  - Table Chart on Comparison by Therapy
  - Table Data Table on Comparison by Therapy
- Targeted therapy - Market size and forecast 2023-2028
  - Table Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
- Hormonal therapy - Market size and forecast 2023-2028
  - Table Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)
- Chemotherapy - Market size and forecast 2023-2028
  - Table Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
- Market opportunity by Therapy
  - Table Market opportunity by Therapy ($ billion)
  - Table Data Table on Market opportunity by Therapy ($ billion)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2023-2028 (%)
  - Table Data Table on Market share by geography 2023-2028 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2023-2028
  - Table Chart on North America - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on North America - Year-over-year growth 2023-2028 (%)
  - Table Data Table on North America - Year-over-year growth 2023-2028 (%)
- Europe - Market size and forecast 2023-2028
  - Table Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Europe - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Asia - Market size and forecast 2023-2028
  - Table Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Asia - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Rest of World (ROW) - Market size and forecast 2023- 2028
  - Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- US - Market size and forecast 2023-2028
  - Table Chart on US - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on US - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on US - Year-over-year growth 2023-2028 (%)
  - Table Data Table on US - Year-over-year growth 2023-2028 (%)
- Germany - Market size and forecast 2023-2028
  - Table Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Germany - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Canada - Market size and forecast 2023-2028
  - Table Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Canada - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
- UK - Market size and forecast 2023-2028
  - Table Chart on UK - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on UK - Year-over-year growth 2023-2028 (%)
  - Table Data Table on UK - Year-over-year growth 2023-2028 (%)
- China - Market size and forecast 2023-2028
  - Table Chart on China - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on China - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on China - Year-over-year growth 2023-2028 (%)
  - Table Data Table on China - Year-over-year growth 2023-2028 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ billion)
  - Table Data Tables on Market opportunity by geography ($ billion)
Drivers, Challenges, and Trends
- Market drivers
  - Rising prevalence of breast cancer
  - Robust pipeline and new drug approvals
  - Rising number of patient support initiatives
- Market challenges
  - High cost of treatment
  - Increasing approvals of biosimilars
  - Tendency of patients to prefer alternative therapeutics
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2023 and 2028
- Market trends
  - Emerging novel therapeutics
  - Availability of improved diagnostic modalities
  - Rise in strategic collaborations
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key news
  - Table AbbVie Inc. - Key offerings
- Amgen Inc.
  - Table Amgen Inc. - Overview
  - Table Amgen Inc. - Product / Service
  - Table Amgen Inc. - Key offerings
- AstraZeneca Plc
  - Table AstraZeneca Plc - Overview
  - Table AstraZeneca Plc - Product / Service
  - Table AstraZeneca Plc - Key news
  - Table AstraZeneca Plc - Key offerings
- Bristol Myers Squibb Co.
  - Table Bristol Myers Squibb Co. - Overview
  - Table Bristol Myers Squibb Co. - Product / Service
  - Table Bristol Myers Squibb Co. - Key news
  - Table Bristol Myers Squibb Co. - Key offerings
- Clovis Oncology Inc.
  - Table Clovis Oncology Inc. - Overview
  - Table Clovis Oncology Inc. - Product / Service
  - Table Clovis Oncology Inc. - Key offerings
- Daiichi Sankyo Co. Ltd.
  - Table Daiichi Sankyo Co. Ltd. - Overview
  - Table Daiichi Sankyo Co. Ltd. - Product / Service
  - Table Daiichi Sankyo Co. Ltd. - Key news
  - Table Daiichi Sankyo Co. Ltd. - Key offerings
- Eisai Co. Ltd.
  - Table Eisai Co. Ltd. - Overview
  - Table Eisai Co. Ltd. - Business segments
  - Table Eisai Co. Ltd. - Key offerings
  - Table Eisai Co. Ltd. - Segment focus
- Eli Lilly and Co.
  - Table Eli Lilly and Co. - Overview
  - Table Eli Lilly and Co. - Product / Service
  - Table Eli Lilly and Co. - Key news
  - Table Eli Lilly and Co. - Key offerings
- Exelixis Inc.
  - Table Exelixis Inc. - Overview
  - Table Exelixis Inc. - Product / Service
  - Table Exelixis Inc. - Key offerings
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key news
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- Merck and Co. Inc.
  - Table Merck and Co. Inc. - Overview
  - Table Merck and Co. Inc. - Business segments
  - Table Merck and Co. Inc. - Key news
  - Table Merck and Co. Inc. - Key offerings
  - Table Merck and Co. Inc. - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Viatris Inc.
  - Table Viatris Inc. - Overview
  - Table Viatris Inc. - Business segments
  - Table Viatris Inc. - Key news
  - Table Viatris Inc. - Key offerings
  - Table Viatris Inc. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations